Clinical Trial Update: "The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

View source ↗

Summary

This clinical trial update reports a study evaluating the combination of a statin and an SGLT2 inhibitor for ischemic heart disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• SGLT2 inhibitor
• Statin (statin)

Snippet

Sponsor: Fayoum University | Conditions: 2 Drugs Are Statin and SGLT2i | Status: RECRUITING